Revision history of "STROKE, AGING AND NEUROGLOBIN: A NEW THERAPEUTIC APPROACH" (Q3213098)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 March 2024

21 December 2023

12 June 2023

10 June 2023

18 August 2022

  • curprev 13:0213:02, 18 August 2022DG Regio talk contribs 106,703 bytes +75,487 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

17 December 2021

9 December 2021

5 December 2021

14 October 2021

  • curprev 08:4408:44, 14 October 2021DG Regio talk contribs 15,041 bytes +116 Changed label, description and/or aliases in en: translated_label
  • curprev 08:4408:44, 14 October 2021DG Regio talk contribs 14,925 bytes +3,587 Created claim: summary (P836): ISCHEMIC STROKE, ONE OF THE MOST IMPORTANT CAUSES OF DEATH AND DISABILITY WORLDWIDE, IS A COMPLEX PROCESS IN WHICH AGE IS THE MAIN RISK FACTOR. DESPITE ITS INCIDENCE, THERE IS CURRENTLY NO EFFECTIVE PHARMACOLOGICAL TREATMENT TO PREVENT NEURODEGENERATIVE DAMAGE ASSOCIATED WITH THIS PATHOLOGY. THIS SITUATION IS PROBABLY DUE TO THE INNUMERABLE PROCESSES THAT UNDERLIE THE STROKE AS WELL AS THE DELICATE BALANCE BETWEEN THEM. NEURONAL DAMAGE ORIGINATE...

11 October 2021

10 October 2021

9 October 2021